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The ten ‘R’s of safe multidisciplinary 
drug administration
Sharon Edwards and Sue Axe
Abstract
Nurses are responsible for medication administration, and, as with many other 
nursing interventions, some risk is involved. If an error occurs, a patient may 
suffer harm or injury, which may lead to a permanent disability or a fatality. To 
ensure safe drug administration, nurses are encouraged to follow the five rights 
(‘R’s; patient, drug, route, time and dose) of medication administration to prevent 
errors in administration. The five ‘R’s do not consider all causes of drug errors; 
instead, they focus on medication administration at the bedside so they relate 
only to this stage of a drug prescription. A drug’s journey is more than what 
happens at the bedside; therefore, the reduction of errors requires more than just 
the five ‘R’s. This article proposes a multi-professional, evidence-based approach 
to medicines management, which all clinicians can work towards, together. 
Clinicians can achieve this approach by considering the National Patients Safety 
Agency’s definition of a medication error and the values set out by the National 
Prescribing Centre. The approach utilizes 10 ‘R’s, which provide a benchmark for 
good practice. The 10 ‘Rs’ advocate the need for the knowledge of the causes of 
drug errors, how to implement strategies to reduce drug errors, how to ensure 
safe practice throughout the medication journey, from chemical preparation, to 
monitoring outcomes, to response.
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It is important for nurses to understand the complexity of medicines 
management. Providing a patient with 
appropriate medication influences 
adherence, concordance, control of 
symptoms and further management. 
Nurses are at the forefront of medication 
interventions and care; therefore, 
they need to understand not only the 
issues related to the administration of 
a drug, incorporating the five rights 
(‘R’s), but also be aware of the full 
medication journey. A drug error 
can occur at any point along the 
medication trajectory, which involves 
a variety of health professionals, such 
as doctors, pharmacists and allied 
health professionals, and not just nurses 
administering drugs at the bedside. 
The National Patient Safety  
Agency (NPSA) was set up to  
monitor drug errors and relates to 
all health professionals involved 
in medications management. The 
competencies of the National  
Prescribing Centre’s framework  
(NPC, 2012) are relevant to all  
medical and non-medical prescribers.
Nurses administering drugs at the 
bedside should continue to use and 
incorporate the five ‘R’s approach to safe 
drug administration; however, nurses 
and other health professionals need 
to consider their roles in medication 
management more broadly, and this  
paper recommends a ten ‘R’s method, 
which can be utilized by all health 
professionals involved in drug 
administration, to aid safe practice.
Medicine errors
Medication administration is not without 
problems. Medication is given with good 
intention, but drugs are poisonous to the 
body and can be dangerous if mistakes 
are made. The NPSA (2007) reports that 
1 in 10 patients experience medication-
related errors. A medicine error can be 
defined as (NPSA, 2007: 6).
‘An error in the process of prescribing, 
dispensing, preparing, administering, 
monitoring or providing medicine  
advice, regardless of whether harm  
has occurred or was possible’
The NPSA (2007) report that 71% of 
fatal and serious harm from medication 
incidents are due to:
  ■ Unclear prescriptions
  ■ The wrong dose being written
  ■ The wrong frequency being prescribed
  ■ The drug being omitted
  ■ The medicine being delayed.
Over half of all drug errors relate to 
dosage, strength, frequency or a failure 
to administer; therefore, ‘omission or 
failure to administer a drug, which 
could compromise patient safety, unless 
appropriate’ should be added to the 
above quote. Other drug errors include 
the wrong quantity being prescribed,  
the drug being intended for another 
patient, poor labelling and storage,  
and out-of-date drugs.
Reason (1990) devised the Swiss chees 
model, which likens the occurrence of 
drug errors to a stack of Swiss cheese 
slices. The holes in the slices of Swiss 
cheese represent a minor error. The 
holes may allow a problem to pass 
through to the next layer, but it can be 
stopped as the holes in the next layer of 
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cheese are in different places. Therefore, 
the more minor errors there are, the 
greater the likelihood of a major error 
getting through. Each layer, therefore, 
is a defence against an error becoming 
realised and affecting the outcome. In 
relation to the journey from prescribing 
to administration, this model explains 
how errors occur if each stage is allowed 
to progress without appropriate defences 
being put in place.
Most medication errors go unreported 
(Nursing and Midwifery Council 
(NMC), 2007). According to NPSA 
(2007), the most serious medication 
incidents reported are caused by errors 
in administration (41%) and to a lesser 
extent, prescribing (32%). Fortunately, 
the majority of medication incidents 
reported have clinical outcomes of no or 
low harm.
Two groups of patients are particularly 
vulnerable to medication errors (Barber, 
2013): children, who are three times more 
likely than the average adult to be subject 
to a medication error (owing mainly to 
the complex calculations required), and 
patients with known allergies.
Causes of drug errors
The five ‘Rs’ (Table 1) were put into place 
in an attempt to reduce drug errors 
(Barber, 2013). Other rights include 
the right reason and documentation 
(Elliott and Liu, 2010). Elliott and Liu 
(2010) argue that the quality of drug 
administration or occurrence of a 
medication error are not solely a matter 
of adhering to the five ‘R’s. Jones (2009) 
states that the use of checklists such as 
the five ‘R’s does not fully address the 
issues related to the causes of medication 
errors. Choo et al (2010) argues that 
these rights fail to reflect human, system 
and environmental factors—the key 
causes of drug errors.
Environment
The literature suggests that many 
medication errors are related to human 
error and environmental factors, since 
drug administration often takes place in 
noisy environments with poor lighting 
(Jones, 2009) (Table 2). Fry and Dacey 
(2007) suggest that to reduce human and 
environmental error, such as distractions, 
protected time during medication 
administration could be introduced. 
This includes the use of a bright tabard 
(Hitchen, 2008) or the use of a visual 
reminder such as a ‘do not disturb’ 
message (Pape et al, 2005), whereby 
patients and staff are discouraged from 
disturbing a nurse who is administering 
medications. However, the effectiveness 
of this intervention in reducing  
human factor errors has not been 
thoroughly researched.
The quality of team communication 
has been linked to improvements in 
patient outcomes (Institute of Healthcare 
Communication, 2011). Therefore, 
conceivably, any links to a reduction 
in medication errors, owing the use of 
a tabard or reminders, is more likely 
to occur because of an improvement 
in team communication, as all team 
members are aware a drug round is being 
performed, thus reducing distractions. 
Attempts to reduce medication 
errors owing to faulty system factors 
have included the introduction of 
information technologies, such as 
computerized physician order entry, 
bar-coding of drugs, and automated 
dispensing devices (Bates, 2000). Fowler 
et al (2009) suggest that technology can 
improve patient safety, but further study 
is required to determine the impact of 
these technologies on the reduction of 
medication errors (Durham, 2015).
Culture
Information regarding the prevention 
and reduction of medicine errors is 
widely available (Bates, 2007). There is 
a need to immediately report all near-
misses and medication errors, regardless 
of whether a patient has been harmed, to 
ensure a learning experience (Armitage, 
2008). However, according to the Agency 
for Healthcare Research and Quality 
(2014), the consequences for nurses 
who report medication errors (such 
as suspension from work, disciplinary 
action, or being reported to the NMC for 
misconduct) can be an issue.
Performance
Nurses can further reduce human 
factors in medication errors (leading to 
morbidity and mortality in hospitalized 
patients) by keeping their skills up to 
date (Sneck et al, 2015). Regular or 
annual updates for nurses verify that 
they are competent in medication 
administration and have theoretical 
knowledge and drug calculation 
skills. The implementation of these 
updates allow policies and procedures 
to represent nurses as autonomous 
Table 1. The five ‘R’s of safe drug 
administration
Number R Information
1 Right patient Ensure medications are administered to the 
correct patient by checking the wristband
2 Right drug The prescription of a drug should be clear and 
legible. The generic name, and not the trade 
name, should be used (unless appropriate). 
Highlight any antiobiotics allergies on the 
wristband as well as on the drug chart
3 Right dosage Check the name of the drug against the dosage 
of the medication to be administered
4 Right time A drug needs to be administered at the 
appropriate time(s) for effective outcomes 
(antibiotics, for example)
5 Right route Some drugs cannot be administered by the oral 
route (GTN or insulin, for example). Others have 
to be administered IV for 100% bioavailability
GTN: glyceryl trinitrate; IV: intravenous
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knowledgeable practitioners, who are 
able to use their own clinical judgement 
without the fear of being accused of or 
causing a drug error. 
However, combining the 5 ‘Rs’ with 
an understanding of the causes of 
drug errors   (owing to factors in the 
environment, culture and performance) 
enables the five ‘Rs’ to be implemented 
correctly. In addition, by ensuring all 
multi-disciplinary teams involved in 
medication management are aware 
of combining the five ‘Rs’ with the 
knowledge of the causes of drug  
errors can further enhance the 
effectiveness of using the five ‘R’s 
approach in error prevention.
This article introduces five new 
‘R’s to consider, which incorporate an 
integrated multi-disciplinary approach, 
supported by evidence.
Multi-disciplinary,  
team, and evidence- 
based approach
In today’s complex health-care system, 
in which patients can access a number of 
health professionals, there is a need for a 
streamlined approach. This idea has been 
recognized by the National Prescribing 
Centre (NPC, 2012), which has developed 
a single competency framework for  
all prescribers—its ethos is that all  
health professionals are involved in  
drug administration.
The NPC framework makes it clear 
that the administration of drugs and the 
occurrence of medication errors is not the 
sole responsibility of nurses at the bedside; 
it is a team effort, in which all members 
work together to ensure safe practice. 
Reduction in medication errors is the 
responsibility of all those involved in the 
preparation of medicines the prescribing 
journey, from drug companies, packaging 
designers, doctors, pharmacists, nurses, 
paramedics, the patient, and policy and 
procedure makers (Table 3).
The competence framework (NPC, 
2012) considers nine areas of competence, 
including participation in the review, the 
development of prescribing to optimize 
patient outcomes, reporting prescribing 
errors and near-misses, and acting upon 
colleagues’ inappropriate prescribing using 
appropriate mechanisms. Yet, Durham 
(2015) highlights that nurses may not 
be aware of a near-miss event or what 
constitutes a medication error, implying 
that Sneck et al’s (2015) proposal of regular 
medication updates may be attractive. 
There is general agreement for strategies 
to be put in place to reduce medication 
errors, and these are generally specific 
to each professional group involved in 
medication management. There is a need 
for a multi-disciplinary approach as 
advocated by the NPC’s (2012) prescribing 
competencies for clinicians. This requires 
an inclusive process that can be utilized 
by all health professionals involved in the 
process of drug administration, providing 
opportunity for reasoning and autonomy. 
In addition to the five ‘R’s’, which nurses at 
the bedside and other health professionals 
can use to safely manage a drug(s) 
episode, five additional ‘Rs’ are proposed. 
The ten ‘R’s approach embraces a broader, 
holistic, integrative multi-disciplinary view 
and encompasses the NPC’s guidelines.
Modifying practice: 
enhancing safety, 
reducing drug errors
The occurence of a drug error may 
not relate solely to human, system or 
environmental error, but a combination 
of them all. To ensure a multi-
Table 2. Causes of medication errors
Human errors Faulty system errors Environmental errors
Poor calculation or competence,  
or lack of confidence
Unclear error reporting processes, 
which provide no clear definitions of 
medication errors and near-miss events
Distractions from other nurses  
or patients (which can be hard  
to ignore)
Poor adherence to prescription/
administration protocols
Limited or no easily accessible 
resources, such as electronic 
databases, to research  
unfamiliar drugs
Lack of awareness of when and where 
an error can occur
Poor knowledge of medications Lack of staff, poor management  
or leadership, or lack of funds
Poor lighting on night shifts
Complacency, misconceptions  
or incorrect interpretations
Ambiguous protocols, policies and 
procedure guidelines for prescribing 
and drug administration
Busy ward
Misinterpretation of packaging 
information (‘not for oral use’,  
for example)
Drug companies’ packaging not clearly 
marked or labelled
Noisy environments
Fatigue, inexperience  
or poor communication
Lack of training and no regular updates 
or courses provided
Time pressures
Medical professionals’ poor 
handwriting or unclear prescriptions
Poor teamwork Increase in nurses’ workload
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professional, evidence-based and 
streamlined approach to reducing errors, 
five more rights (‘R’s) are put forward:
  ■ The right to refuse (patient and nurse, 
including autonomy)
  ■ Knowledge and understanding
  ■ Right questions (including reason)
  ■ Right response (including 
documentation)
  ■ Right advice.
6. The right to refuse (patient  
and administrator)
The current five ‘R’s fail to consider the 
intricacies associated with administering 
medications in more complex settings; for 
example, when a patient refuses to take a 
prescribed medication. The patient may 
have a difficulty in taking the medicine 
(such as trouble with swallowing) or 
they may not perceive the need for the 
medication. A sixth right is implied: the 
right of the patient to refuse a drug.
The right to refuse can also 
incorporate the right of a nurse to refuse 
to administer a prescribed drug, as nurses 
should not thoughtlessly obey ‘orders’. 
If the prescription has been incorrectly 
written, the prescription is ambiguous, 
or the nurse doubts the legitimacy of the 
prescription, the nurse has a right not to 
give or administer the drug to the patient.
However, problems can arise here—if 
a nurse omits or fails to administer a 
drug or does not give it at the correct 
time, these incidences can constitute a 
medication error, and the nurse is placed 
in a difficult position. If nurses refuse to 
administer a drug on the grounds that the 
prescription is inappropriately written,  
or if an inappropriate preparation is  
to be given, this may also constitute  
a drug error.
According to the NMC (2015), 
medicine administration should be 
evidence-based, so nurses can refuse or 
omit a drug, referring to sound evidence-
based practice, yet can still be accused of 
a drug error. For example, the refusal of 
potassium supplements on the grounds 
that the patient’s potassium level is too 
high (by checking daily blood results) 
or the refusal of digoxin, as the apex 
and redial pulses were below 60 beats 
per minute. These issues question the 
policies and procedures, which may fail 
to represent the nurses as autonomous 
and knowledgeable practitioners, who are 
able to use their own clinical judgement 
in such situations without the fear of 
being accused of a drug error. With the 
increase in independent prescribing by 
disciplines other than in the medical 
profession, nurses may find themselves 
administering drugs prescribed by 
non-medical prescribers (pharmacists, 
physiotherapists and other nurses, for 
example), which may add to the complex 
nature of patient management and the 
right to refuse.
7. Right knowledge  
and understanding 
The seventh ‘R’ regards in-depth 
knowledge and understanding of (Table 4):
  ■ The naming of a drug
  ■ How the body affects the drug 
(pharmacokinetics)
  ■ How the drug affects the body 
(pharmacodynamics)
  ■ Side-effects of drugs
Table 3. A medication error can occur from preparation to outcome
Stage in the drug’s journey Responsibility Relationship to the five ‘R’s
Chemical preparation  
and drug naming
Drug companies Drug
Packaging Packaging companies and drug  
label designers
Drug, route
Prescribing and transcribing Doctor, nurse prescriber or the nurse 
checking drugs
Drug, patient, time, route, dosage
Preparing (in the ward  
and community)
Formulation prepared by pharmacist—
liquid form, tablet form or IV
Drug, dosage, route, patient
Dispensing Pharmacist from pharmacy to ward  
or community setting
Drug, dosage, route, patient
Omission, failure to administer,  
or increase or decrease in period  
of time between drugs
Refusal to administer drug by health 
professional, or refusal to take the drug 
by the patient
Drug, dosage, route, patient
Administration Nurse, doctor or non-medical 
professional
Drug, patient, route, dosage
Providing medication advice Nurse, doctor or non-medical 
professional
Not applicable
Monitoring, outcome and response Nurse, doctor, pharmacist  
or paramedic
Not applicable
IV: intravenous
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Table 4. Knowledge and understanding of pharmacology required  
for safe drug administration
Principles Knowledge Understanding
Nomenclature  
classification of drugs
■ Therapeutic use
■ Mode of action
■ Molecular structure
■ To cure, suppress or prevent disease
■ How a drug exerts its effect on the body
■ Knowledge of molecular structure and the drug’s 
similarity to other drugs, which usually have similar action
Naming of drugs ■ Chemical name
■ A generic name
■ A trade name
■  Chemical names are sometimes used (glycerin 
trinitrate, for example)
■  Generic names are decided when a drug can be 
used (for NHS prescribing) [AQ: This is a little unclear. 
Please explain this]
■  Given by the company
Pharmaceutics ■  Preparation of a drug 
into convenient form for 
administration, and the 
formulation of drugs
■  Drugs are administered by 
mouth via the gut or parenteral 
(all other routes)
The aims of administration of a drug are to:
■  Establish optimal concentration at the target site
■  Maintain optimal concentration for the required 
period of time
■  Minimize adverse drug reactions owing to 
general distribution
Pharmacokinetics ■  What the body does to 
the drug
■  The passage of a drug through 
the body
Absorption—the method of administration, how the 
drug gets across a cell membrane, before entering the 
systemic circulation
Distribution—the drug then has to travel through the 
body from site of insertion to site of action
Metabolism—the drug arrives at its destination and has 
to be metabolized: 
■  This occurs in the liver, where the drug is transformed 
into substances that are easier to excrete
■  The first-pass metabolism process inactivates some 
drugs, which are absorbed in the gastrointestinal tract 
and directly pass into the blood stream, to the liver
Excretion—occurs by the kidneys via urine: 
■  When a patient has some form of renal impairment 
drug dosage needs to be reduced
■  In some instances, frequent blood samples may be 
required (for digoxin and gentamicin, for example)
■  Excretion can also occur in the faeces, lungs and skin
Pharmacodynamics ■  What the drug does to 
the body, including both 
therapeutic and adverse side-
effects of the drug
■  Many drugs cause their effects 
by combining with receptors, 
and each responds to a 
different chemical or hormone
Agonist drugs, which interact with a receptor mimicking 
the effect of a natural mediator
Partial agonist drugs, whose maximal response falls 
short of the full response
Antagonists block the effect of the natural mediator 
at a receptor to prevent an effect
Selective, but not specific, drugs (which act on more than 
one receptor and produce side-effects, which lead to dry 
mouth, blurred vision, constipation and drowsiness)
Inhibiting enzymes in the body 
Adverse effects and drug 
toxicity
■  No drug is 100% safe
■  All drugs have side-effects 
and these are usually 
predictable and dose-related
Drug toxicity can occur, and the drug may be allowed to 
build up in the system. Other drugs the patient may be 
taking have to be taken into account (polypharmacy). 
Drugs are more toxic in:
■  The very elderly and the very young
■  Patients with underlying pathologies
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Table 4. Continued
Principles Knowledge Understanding
Poisoning and overdose 
can be intentional, 
accidental, iatrogenic or 
through criminal intent
Specific antidotes are available 
for few poisons or drugs. The 
general principles of a drug 
overdose are:
■  Diagnosis (timing, limiting 
the period for ingestion of the 
drug)
■  Assessment (ABCDE, 
investigations and drug levels)
■  Resuscitation and drug 
manipulation
Drug manipulation attempts to: 
■  Decrease absorption of the drug by administering 
an emetic, giving a gastric lavage, an absorbent 
(such as activated charcoal), or a cathartic (such as 
magnesium citrate or magnesium sulphate)
■  Increase excretion by forced diuresis (diuretics), 
producing an alkalosis through hyperventilation, or 
administration of sodium bicarbonate, or commencing 
haemodialysis
■  Administration of the specific overdose antidote for 
paracetamol (Parvolex), narcotic (naloxone, also 
known as Narcan), heparin (protamine sulphate)  
and warfarin (vitamin K)
Drug interactions This is when two or more drugs 
are given at the same time and 
exert their effects independently 
or may interact with one another. 
A drug’s action may be:
■  Suppressed
■  Rendered completely inactive
■  Increased
■  An antagonism of one drug by 
another
■  Some other effect
Combinations of drugs need to 
be carefully considered to avoid 
drug interactions
All interactions need to be reported and are due to 
pharmacokinetic or pharmacodynamics interactions
Pharmacokinetic interactions can affect drug absorption 
leading to ineffective therapy through: 
■  An antagonism for one drug by another or the affect 
of the metabolism of another; for example, in the liver, 
leading to an increased risk of toxicity or affecting 
renal excretion
■  There can be competition for excretion in renal 
tubules leading to delay in excretion with the possible 
risk of toxicity
Pharmacodynamic interactions through:
■  Competition of drugs at receptor sites 
■  Changes in protein binding, which increases the free 
drug in plasma and so increasing the action of the 
drug on the body
■  There can also be interaction between drugs acting 
on the same physiological system (diuretics, for 
example)
ABCDE: airway, breathing, circulation, disability and exposure
  ■ Drug toxicity
  ■ Interactions 
  ■ Poisoning.
This knowledge should include how  
to prepare and store medicines in line 
with local policy and knowledge of 
appropriate monitoring before medicines 
are administered (blood tests to check  
for drug levels and kidney function,  
for example).
Additionally, a large number of health-
care assistants (HCAs) are employed 
in today’s health-care system, and 
some can administer medicines; HCAs 
should have the same level of knowledge 
and understanding as other health 
professionals, such as how the medicine 
works, interactions with other medicines 
and potential side-effects. Qualified 
nurses and prescribers (whether they are 
nurses, doctors, pharmacists or allied 
health professionals) have a duty to 
ensure the staff delegated to administer 
medicines have sufficient knowledge to 
undertake the task safely. 
8. Right questions being asked
The eighth ‘R’ involves considering 
whether the drug is appropriate in 
relation to the condition being treated, 
but also for the patient. For example, 
has the correct prescription, with clear 
unambiguous instructions, been written 
up? Dosing schedules, formulation 
and the exact nature of the condition 
being treated (‘is the drug being given 
for the right reason(s)?’) should also 
be considered. Concordance can be 
improved by considering the frequency 
of dosing and specific timings of drug 
administration. For example, a slow-
release preparation may be given less 
frequently and may also cause fewer 
side-effects. Is the formulation the most 
appropriate for the patient? The very 
young and elderly may require liquid 
preparations for ease of swallowing, 
as crushing of drugs should not be 
the norm. Is the drug being used 
appropriately or is it to treat a  
side-effect of a medication the patient  
is already taking that could be dealt  
with by considering another group  
 of drugs? 
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Table 5. The ten ‘R’s for safe multidisciplinary drug administration
To reduce distractions, consider protected time, the use of a bright tabard or the use of a visual 
reminder (such as ‘do not disturb’), communicating to others that you are not to be interrupted
Before administration
The ten ‘R’s Consider the following:
1 Right patient ■ Has this patient been prescribed the drug?
■ Has the patient’s name band been checked? Is there a clear 
patient identifier?
■ Does the patient know they are receiving the drug and why?
Before administration
2 Right drug ■  Do you know where to obtain the drug? Are all drugs in one 
location and are they clearly labelled?
■  Is this the drug that has been prescribed? Is there a drug with 
a similar name?
■  If appropriate, has the drug been checked by another nurse 
or health professional?
During preparation
3 Right dosage ■  Is the dose appropriate or usual for the drug being prescribed?
■  If appropriate, has the dose or calculation been checked by 
another nurse or health professional?
4 Right time ■  Has the time gap between each drug administration been 
adequate, sufficient, too short or too long?
5 Right route ■  Is the route appropriate for the drug being prescribed?
6 Right to refuse 
(patient and nurse)
■  Are you able to exercise your clinical judgement and refuse to 
give or omit the drug? Do you have a rationale for this and are 
you able to demonstrate or explain this to others?
■  Do you know what action to take if the patient refuses the 
prescribed medication? 
■  Can you identify the barriers to medication administration 
and identify suitable approaches to address them (dysphagia  
or confusion, for example)?
Immediately before 
administration
7 Right knowledge ■  Do you know what monitoring is required prior to administration?
■  Do you know how to prepare and administer the medication in 
line with local policies?
■  Do you know the preferences of the patient?
■  Do you understand the pharmacokinetics, pharmacodynamics, 
action, possible interactions, side-effects, expected positive 
outcome(s), and/or the possible occurrence of adverse effects 
(toxicity), or overdose of the drug(s) you are administering?
■  Do you understand the law related to the particular drug(s)?
8 Right questions  
or challenges
■  Is this the right prescription, appropriate drug(s) for the patient’s 
condition(s)? Is the prescription written correctly and clearly, with 
clear unambiguous instructions?
■  Can the writing be easily read?
■  Can you communicate with other professionals if needed?
■  Is there access to available resources (drug formularies and/or 
product information leaflets)?
9 Right advice ■  Does the patient know about the drug? If not, can you give the 
patient advice/details/information about this/these medication(s)?
After administration
10 Right response  
or outcome
■  Do you know the expected response/outcomes of the drug?
■  Do you know how to observe/check for allergic reactions, drug 
interaction(s), side-effects and call for assistance?
■  Do you know how and when to complete records of administration 
in line with local policy and document any changes?
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Owing to the aging population, 
many patients find themselves on 
multiple drugs, which may expose them 
to adverse effects from interactions. 
Polypharmacy can be appropriate (when 
a patient is being treated for more than 
one long-term condition, for example), 
but it may be inappropriate if a patient 
is taking medicines to treat the side-
effects of other medications, or several 
drugs with similar actions. The potential 
for drug interactions is 6% when taking 
two different drugs, 50% when taking 
five different drugs and 100% when 
taking eight or more drugs (Crouch and 
Chapelhow, 2008).
A further consideration is that 
the patient may see many different 
clinicians, whom consider the patient 
in relation to a specific condition. The 
person administering the medication 
may identify duplicate medications or 
potential interactions. This may occur 
particularly at the interface between 
secondary and primary care when a 
patient is discharged home with an 
altered medication regimen that is not 
immediately implemented. Pharmacists, 
doctors, and, increasingly, non-medical 
prescribers, are all in a position to 
undertake medication reviews to identify 
potential errors and to stop medicines 
when they are no longer required.
Another area of challenge is in 
intravenous (IV) drug administration, 
and gauging when to stop IV and 
commence oral administration in 
response to the level of seriousness of 
the patient’s condition. If the route (IV, 
for example) is no longer appropriate, 
the nurse has the right to refuse to 
administer the drug and request that  
the drug be changed to the oral 
formation of the same drug. Health 
professionals should not be afraid 
to question other members of staff 
and prescribers, however senior, if 
they suspect that a medicine is not 
appropriate for a patient.
9. Right advice
The ninth ‘R’ suggests that all health 
professionals who prescribe or 
administer a drug should be able 
to provide advice about its actions, 
indications, side-effects, the importance 
of taking the drug at the correct time and 
the expected outcome of the drug(s). A 
patient should be informed by the nurse, 
and should understand the medication 
and side-effects. The nurse can  also work 
towards obtaining insight into patient 
preferences and their health beliefs in 
relation to taking their medication.
Berry et al (2006) identify five top 
information-giving priorities in  
nurse prescribing: 
  ■ Possible side-effects
  ■ What the medicine does
  ■ How it works
  ■ Probability of the medicine’s 
effectiveness
  ■ The risks of not taking the medicine
  ■ How medicines will interact with  
each other.
This paper proposes that all health 
professionals have a responsibility to 
communicate these essential pieces 
of information to contribute to the 
therapeutic relationship between the 
clinician and patient, and to improve 
medication adherence.
10. Right response 
The tenth ‘R’ relates to the review of the 
patient. Is the outcome as expected? 
For example, has a course of antibiotics 
resolved or is it resolving the infection? 
The right response is also concerned 
with providing monitoring of the drug to 
establish the continuing effect of the drug 
(reduced blood pressure and heart rate, 
and improved air entry and lung sounds, 
for example). Importantly, this ‘R’ is also 
concerned with the safety of using the 
drug in the individual patient. Has any 
harm come to the patient (allergy, adverse 
effect, drug interaction, or side-effects, for 
example)?
The right response, again, is the 
responsibility of all health professionals 
involved with medicines management. 
This includes the documentation of 
medicines prescribed and administered, 
a review of the patient and their response 
to the medicine. All should form an 
integral part of the written record to 
provide continuity of care across the 
team caring for the patient. In addition, 
the right response is about recording and 
notifying relevant parties about adverse 
drug reactions or interactions, so that 
documentation can be updated in relation 
to allergy status if appropriate.
In relation to public health, it is also 
necessary to inform the Medicines and 
Healthcare products Regulatory Agency 
(MHRA) of significant adverse affects to 
drugs through the Yellow Card system 
(Joint Formulary Committee, 2015). 
Finally, the right response is concerned 
with ‘safety netting’—nurses, doctors and 
other prescribing and non-prescribing 
professionals should explain to a patient 
what they should do if progress is not as 
expected with their medicines and  
what action they should take. This 
information should also be recorded  
in the patient’s notes. 
Discussion
The standardized five ‘R’s, advocated 
by the NMC (2006; 2007), are adequate 
for nurses to incorporate into their 
care at the bedside to facilitate safe 
administration of medication. However, 
the NPC framework (2012) makes 
it clear that the responsibility for 
managing the environment in which 
drug administration takes place, and 
reducing the possibility of drug errors, is 
a multi-disciplinary concern. Therefore, 
there is a requirement for all health 
professionals to employ a broader, 
holistic understanding of medication 
management, as no single health 
professional group is responsible  
for all drug errors.
A drug error can occur at any stage  
of the drug’s journey from preparation 
and prescription to outcome (Table 3). 
Elliott and Liu (2010) suggest that only  
a small proportion (between 26 and  
38%) of errors are nursing-related. 
Therefore, a majority (between 62 and 
74%) of medication errors are due to 
other factors. 
All doctors, and prescribing and 
non-prescribing professionals including 
nurses, must aim to provide safe 
medication administration, which is 
based on evidence of the purpose of the 
prescribed drug(s), what the body does 
to the drug and the action of the drug 
on the body. The NMC (2015) advises 
on nurses should only prescribe, advise 
about or provide treatment or medicines 
if they have enough knowledge about 
the person’s health and are sure that the 
treatment or medicine serves the person’s 
health needs. In addition, a nurse must 
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make sure that the advice given takes 
into account other care the person is 
receiving; thus, drug administration is a 
holistic episode of care.
This paper takes a multi-professional 
approach to drug administration 
and the prevention of drug errors, 
and recommends the 10 ‘Rs’ as a 
benchmark to multi-professional 
safe drug administration (Table 5). It 
includes considerations to follow before 
the drug round, during preparation, 
immediately before administration 
and afterwards. These considerations 
are flexible and encompass the need to 
include professionals’ thinking during 
medication administration. 
Lawton and Parker (1999), and 
Eisenhauer et al (2007), recognized that 
administering drugs extends beyond 
protocols, policies or checklists, which 
are considered not to be useful, as they 
restrict the professional’s ability to make 
autonomous decisions. The inclusion of 
discretion in medication administration, 
as in the 10 ‘R’s approach, values the 
complex thought processes required, 
which can be beneficial to prescribing 
and non-prescribing professionals 
and patients, to ensure safe practice is 
maintained.
Visual reminders have been used 
as a means to guide medication 
administration (Pape et al, 2005). 
Hospitals, community health care, 
GPs, ambulance services, and 
pharmacies can display the ten ‘R’s as a 
benchmark to good practice of safe drug 
administration’ (Table 5) as a prompt, 
to encourage compliance with the ‘R’s 
and improve the safety of medication 
administration.
Conclusion
Part of the nurse’s role is the 
administering of drugs, which should 
be carried out in compliance with the 
five ‘R’s. It is increasingly common for 
experienced, suitably qualified nurses 
and allied health professionals to 
prescribe drugs too, but the journey from 
chemical preparation to prescribing, to 
administering, to determining outcome 
is complex, fraught with dangers, and 
a drug error could be due to more than 
just the wrong drug being prescribed 
or the wrong dose being calculated. 
Understanding of nomenclature, 
pharmaceutics, pharmacokinetics, 
pharmacodynamics, therapeutics are 
essential for all involved. Thus, no 
health professional should administer 
a drug if they do not know what it 
is for, are not able to explain it to 
the patient, do not understand the 
outcome of its administration or are 
unable to notice the side-effects. Drug 
administration is not a simple task; it 
demands clinical judgement before and 
during preparation, immediately before 
administration and afterwards.
This paper puts forward a proposal to 
merge the five ‘R’s with the knowledge 
of the causes of drug errors, to broaden 
perspectives to the idea of medication 
management as a muli-professional, 
evidence-based endeavour. This involves 
merging the understanding of the 
causes of errors, and the strategies to 
reduce them accumulated so far, with 
the original five ‘R’s, with consideration 
to a further five ‘R’s, to give a ten ‘R’s 
approach. The ten ‘R’s can serve all 
disciplines involved in medication 
episodes and provide a benchmark for 
good practice that is based on sound 
knowledge and evidence.
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